http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2759299-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca32fd2a44fd326ffd027a75a57bd13f |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-726 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-726 |
filingDate | 2013-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2014-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-2759299-A1 |
titleOfInvention | Galactosaminogalactan comprising alpha 1-4 linked galactose and alpha 1-4 linked N-acetylgalactosamine for use in the treatment of at least one inflammatory disease |
abstract | A first object of the invention is galactosaminogalactan comprising α1-4 linked galactose and α1-4 linked N-acetylgalactosamine for use in the treatment of at least one inflammatory disease. Another objet of the invention is a pharmaceutical composition comprising a galactosaminogalactan comprising α1-4 linked galactose and α1-4 linked N-acetylgalactosamine as defined in any of the above-cited claims, and optionally a pharmaceutically acceptable carrier. Another object of the invention is a pharmaceutical composition according to the invention, for use in the treatment of at least one inflammatory disease. Another object of the invention is an inhibitor of IL-1 RA for use in the treatment of human fungal diseases. Another object of the invention is a pharmaceutical composition comprising an inhibitor of IL-1 RA, and optionally a pharmaceutically acceptable carrier. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11077135-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3334435-A4 |
priorityDate | 2013-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1322.